Increase in Perioperative Complications Following Primary Total Hip and Knee Arthroplasty in Patients With Hepatitis C Without Cirrhosis

被引：45

作者：

Best, Matthew J. ^{[1
]}

Buller, Leonard T. ^{[1
]}

Klika, Alison K. ^{[2
]}

Barsoum, Wael K. ^{[2
]}

机构：

[1] Univ Miami, Dept Orthopaed Surg & Rehabil, Miller Sch Med, Miami, FL 33130 USA

[2] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA

来源：

JOURNAL OF ARTHROPLASTY | 2015年 / 30卷 / 04期

关键词：

hepatitis C; total joint arthroplasty; total hip arthroplasty; total knee arthroplasty; transfusion; TOTAL JOINT ARTHROPLASTY; VIRUS-INFECTION;

D O I：

10.1016/j.arth.2014.11.013

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

100224 [整形外科学];

摘要：

The effects of hepatitis C on primary total hip (THA) and knee (TKA) arthroplasties are poorly understood. The National Hospital Discharge Survey was used to identify patients who underwent THA or TKA between 1990 and 2007 without a diagnosis of cirrhosis, HIV, or hepatitis A, B, D or E virus infection. Patients were split into two groups: 1) hepatitis C (n = 26,444) and 2) non-hepatitis C (n = 8,336,882) and analyzed for differences in length of hospital stay, discharge status and perioperative complications. Those with hepatitis C had shorter hospital stays, higher rates of nonroutine discharge and higher odds of in-hospital complications (OR: 1.686, range: 1.645-1.727), surgery related complications (OR: 1.559, range: 1.516-1.603) and general medical complications (OR: 2.012, range: 1.961-2.064) (P < 0.001). (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：663 / 668

页数：6

共 49 条

[1]

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection [J].

Andreone, Pietro ;

Colombo, Massimo G. ;

Enejosa, Jeffrey V. ;

Koksal, Iftihar ;

Ferenci, Peter ;

Maieron, Andreas ;

Muellhaupt, Beat ;

Horsmans, Yves ;

Weiland, Ola ;

Reesink, Henk W. ;

Rodrigues, Lino, Jr. ;

Hu, Yiran B. ;

Podsadecki, Thomas ;

Bernstein, Barry .

GASTROENTEROLOGY, 2014, 147 (02) :359-+

[2]

Bean JHK, 1992, VITAL HLTH STAT DATA, P1

[3]

Blundell CR, 1981, CONT ANESTH PRACT, V4

[4]

Bohl DD, 2014, CLIN ORTHOP RELAT R, V472, P6

[5]

Bot AG, 2014, J SHOULDER ELB SURG, V23, P4

[6]

Brennan TA, 2014, ANAL REAL WORLD SOVA

[7]

Buezo GF, 1996, INT J DERMATOL, V35

[8]

CDC/National Center for Health Statistics, 2013, INT CLASS DIS 9 REV

[9]

Centers for Disease Control and Prevention, 2014, NAT HOSP DISCH SURV

[10]

Hepatitis C virus infection in USA: an estimate of true prevalence [J].

Chak, Eric ;

Talal, Andrew H. ;

Sherman, Kenneth E. ;

Schiff, Eugene R. ;

Saab, Sammy .

LIVER INTERNATIONAL, 2011, 31 (08) :1090-1101

← 1 2 3 4 5 →